Moderna, Inc.
Short

$MRNA rejected at 160 resistance, can retest 138 support again

94
MRNA rejected at 160 resistance, can retest 138 support again

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.